Evidence map›Paper›PMID 31886278›Full record

ReviewJournal of diabetes research2019

Myoinositol in the Prevention of Gestational Diabetes Mellitus: Is It Sensible?

Angelika Sobota-Grzeszyk, Mariusz Kuźmicki, Jacek Szamatowicz

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of diabetes research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Angelika Sobota-GrzeszykDepartment of Gynecology and Gynecological Oncology, Medical University of Bialystok, 15-276 Bialystok, Poland.ORCID https://orcid.org/0000-0001-8035-0139
Mariusz KuźmickiDepartment of Gynecology and Gynecological Oncology, Medical University of Bialystok, 15-276 Bialystok, Poland.
Jacek SzamatowiczDepartment of Gynecology and Gynecological Oncology, Medical University of Bialystok, 15-276 Bialystok, Poland.ORCID https://orcid.org/0000-0001-8632-7829
Medical University of Białystok · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is a complication that increasingly affects pregnant women. Due to the risk of adverse outcomes in the mother as well as in the fetus which is caused by GDM, appropriate diagnosis and treatment is very essential. Nevertheless, it is important to find new, effective ways of prevention of GDM to avoid side effects. A promising example of such an action may be supplementation of myoinositol. As shown in studies, myoinositol may reduce the risk of developing gestational diabetes mellitus by improving insulin sensitivity.

Indexed as

Dietary SupplementsAnimalsBiomarkersBlood GlucoseDiabetes, GestationalFemaleHumansHypoglycemic AgentsInositolInsulin ResistancePregnancyRisk AssessmentRisk FactorsTreatment OutcomeBiomarkersBlood GlucoseHypoglycemic AgentsInositol

Identifiers

PMID31886278
PMCPMC6925787
OpenAlexW2994605448

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.